Showing results (301-310 of 430) with videos related to

Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Clinical significance of thrombospondin 1 expression in hepatocellular carcinomaRonnie T Poon, Ka Kit Chung, Siu Tim Cheung, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 8, 2012
Rapid measurement of indocyanine green retention by pulse spectrophotometry: a validation study in 70 patients with Child-Pugh A cirrhosis before hepatectomy for hepatocellular carcinomaTan To Cheung, See Ching Chan, Kenneth S H Chok, et al.
Annals of Surgery|June 24, 2004
FK 409 ameliorates small-for-size liver graft injury by attenuation of portal hypertension and down-regulation of Egr-1 pathwayKwan Man, Terence K Lee, Ting Bo Liang, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?Albert C Y Chan, See Ching Chan, Kenneth S H Chok, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|December 13, 2012
Radiological prognosticators of hepatocellular carcinoma treated by hepatectomyKevin K W Chu, See Ching Chan, Sheung Tat Fan, et al.
Digestive Diseases and Sciences|May 10, 2014
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2Felice H Tsang, Victor Au, Wen-Jing Lu, et al.
Hepatology International|April 13, 2011
Validation of graft and standard liver size predictions in right liver living donor liver transplantationSee Ching Chan, Chung Mau Lo, Kenneth S H Chok, et al.
Oncology|December 22, 2007
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinomaThomas Yau, Pierre Chan, Hilda Wong, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 13, 2012
High-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients awaiting liver transplantationTan To Cheung, Kenneth S H Chok, Regina C L Lo, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 12, 2009
Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258Yuqing Liu, Xiao Ming Wen, Eric Lik Hang Lui, et al.
Pageof 43